Roivant Sciences Ltd. - COMMON STOCK (ROIV)

CUSIP: G76279101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
714,963,624
Total 13F shares
497,346,775
Share change
+38,332,999
Total reported value
$5,012,967,398
Put/Call ratio
17%
Price per share
$10.08
Number of holders
178
Value change
+$397,737,203
Number of buys
113
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP G76279101?
CUSIP G76279101 identifies ROIV - Roivant Sciences Ltd. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Roivant Sciences Ltd. - COMMON STOCK (ROIV) as of Q2 2023

As of 30 Jun 2023, Roivant Sciences Ltd. - COMMON STOCK (ROIV) was held by 178 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 497,346,775 shares. The largest 10 holders included QVT Financial LP, SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, Patient Square Capital LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., and STATE STREET CORP. This page lists 178 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.